Tenon Medical (TNON) Proxy Filing summary

Executive summary

• The 2024 Annual Meeting will be held virtually on July 23, 2024, with voting on key proposals including director elections, preferred stock terms, equity plan amendments, auditor ratification, and potential adjournment.

• Stockholders of record as of June 3, 2024, are eligible to vote, with materials distributed primarily via the internet to expedite delivery and reduce costs.

• The Board recommends voting in favor of all proposals, emphasizing their alignment with the company's and stockholders' best interests.

Voting matters and shareholder proposals

• Proposals include electing six directors, approving Series B Preferred Stock and related warrants, amending the 2022 Equity Incentive Plan, ratifying the appointment of Haskell & White LLP as auditor, and authorizing adjournment if needed.

• The Board recommends a "FOR" vote on all proposals.

• Stockholders may submit proposals for the 2025 Annual Meeting by April 24, 2025, following specific bylaw procedures.

Board of directors and corporate governance

• The Board consists of six directors, with three deemed independent under Nasdaq rules.

• Directors are elected annually, and the Board met five times in 2023, with high attendance.

• The Nominating and Corporate Governance Committee evaluates candidates for diversity, experience, and integrity.

• The Board has Audit, Compensation, and Nominating and Corporate Governance Committees, each with defined charters and responsibilities.